{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T16:17:49Z","timestamp":1769012269734,"version":"3.49.0"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2003,10,23]],"date-time":"2003-10-23T00:00:00Z","timestamp":1066867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,10,23]],"date-time":"2003-10-23T00:00:00Z","timestamp":1066867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2004,1,1]]},"DOI":"10.1038\/sj.leu.2403171","type":"journal-article","created":{"date-parts":[[2003,10,23]],"date-time":"2003-10-23T09:27:04Z","timestamp":1066901224000},"page":"11-17","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["NF-\u03baB\/Rel-mediated regulation of apoptosis in hematologic malignancies and normal hematopoietic progenitors"],"prefix":"10.1038","volume":"18","author":[{"given":"M C","family":"Turco","sequence":"first","affiliation":[]},{"given":"M F","family":"Romano","sequence":"additional","affiliation":[]},{"given":"A","family":"Petrella","sequence":"additional","affiliation":[]},{"given":"R","family":"Bisogni","sequence":"additional","affiliation":[]},{"given":"P","family":"Tassone","sequence":"additional","affiliation":[]},{"given":"S","family":"Venuta","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2003,10,23]]},"reference":[{"key":"BF2403171_CR1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1146\/annurev.immunol.16.1.225","volume":"16","author":"S Ghosh","year":"1998","unstructured":"Ghosh S, May MJ, Kopp EB . NF-\u03baB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998; 16: 225\u2013260.","journal-title":"Annu Rev Immunol"},{"key":"BF2403171_CR2","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.immunol.18.1.621","volume":"18","author":"M Karin","year":"2000","unstructured":"Karin M, Ben-Neriah Y . Phosphorylation meets ubiquitination: the control of NF-\u03baB activity. Annu Rev Immunol 2000; 18: 621\u2013623.","journal-title":"Annu Rev Immunol"},{"key":"BF2403171_CR3","first-page":"RE1","volume":"5","author":"DM Rothwarf","year":"1999","unstructured":"Rothwarf DM, Karin M . The NF-\u03baB activation pathway: a paradigm in information transfer from membrane to nucleus. Sci STKE 1999; 5: RE1.","journal-title":"Sci STKE"},{"key":"BF2403171_CR4","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1182\/blood.V98.9.2603","volume":"89","author":"I Herr","year":"2001","unstructured":"Herr I, Debatin K-M . Cellular stress response and apoptosis in cancer therapy. Blood 2001; 89: 2603\u20132614.","journal-title":"Blood"},{"key":"BF2403171_CR5","doi-asserted-by":"crossref","first-page":"6938","DOI":"10.1038\/sj.onc.1203221","volume":"18","author":"B Rayet","year":"1999","unstructured":"Rayet B, G\u00e8linas C . Aberrant rel\/nf\u03bab genes and activity in human cancer. Oncogene 1999; 18: 6938\u20136947.","journal-title":"Oncogene"},{"key":"BF2403171_CR6","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1126\/science.274.5288.782","volume":"274","author":"AA Beg","year":"1996","unstructured":"Beg AA, Baltimore D . An essential role of NF-\u03baB in preventing TNF-\u03ba-induced cell death. Science 1996; 274: 782\u2013784.","journal-title":"Science"},{"key":"BF2403171_CR7","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0092-8674(00)81375-6","volume":"87","author":"Z-G Liu","year":"1996","unstructured":"Liu Z-G, Hsu H, Goeddel DV, Garin M . Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-\u03baB activation prevents cell death. Cell 1996; 87: 565\u2013576.","journal-title":"Cell"},{"key":"BF2403171_CR8","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1126\/science.274.5288.787","volume":"274","author":"DJ Van Antwerp","year":"1996","unstructured":"Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM . Suppression of TNF-\u03ba-induced apoptosis by NF-\u03baB. Science 1996; 274: 787\u2013789.","journal-title":"Science"},{"key":"BF2403171_CR9","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1126\/science.274.5288.784","volume":"274","author":"CY Wang","year":"1996","unstructured":"Wang CY, Mayo MW, Baldwin AS . TNF- and cancer therapy induced apoptosis: potentiation by inhibition of NF-\u03baB. Science 1996; 274: 784\u2013787.","journal-title":"Science"},{"key":"BF2403171_CR10","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1002\/j.1460-2075.1996.tb00845.x","volume":"15","author":"M Wu","year":"1996","unstructured":"Wu M, Lee H, Bellas RE, Schauer SL, Arsura M, Katz D et al. Inhibition of NF-\u03baB\/Rel induces apoptosis of B cells. EMBO J 1996; 15: 4682\u20134690.","journal-title":"EMBO J"},{"key":"BF2403171_CR11","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ni0302-221","volume":"3","author":"M Karin","year":"2002","unstructured":"Karin M, Ling A . NF-\u03baB at the crossroads of life and death. Nat Immunol 2002; 3: 221\u2013227.","journal-title":"Nat Immunol"},{"key":"BF2403171_CR12","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/7410","volume":"5","author":"CY Wang","year":"1999","unstructured":"Wang CY, Cusack Jr JC, Liu R, Baldwin Jr AS . Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-\u03baB. Nat Med 1999; 5: 412\u2013417.","journal-title":"Nat Med"},{"key":"BF2403171_CR13","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/sj.leu.2402143","volume":"15","author":"MK White","year":"2001","unstructured":"White MK, McCubrey JA . Suppression of apoptosis: role in cell growth and neoplasia. Leukemia 2001; 15: 1011\u20131021.","journal-title":"Leukemia"},{"key":"BF2403171_CR14","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1172\/JCI11991","volume":"107","author":"AS Baldwin","year":"2001","unstructured":"Baldwin AS . Control of oncogenesis and cancer therapy resistance by the transcription factor NF-\u03baB. J Clin Invest 2001; 107: 241\u2013246.","journal-title":"J Clin Invest"},{"key":"BF2403171_CR15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1471-4914(02)02375-4","volume":"8","author":"RZ Orlowski","year":"2002","unstructured":"Orlowski RZ, Baldwin AS . NF-\u03baB as a therapeutic target in cancer. Trends Mol Med 2002; 8: 385\u2013390.","journal-title":"Trends Mol Med"},{"key":"BF2403171_CR16","first-page":"191","volume":"8","author":"S Mathew","year":"1993","unstructured":"Mathew S, Murty VV, Dalla-Favera R, Chaganti RS . Chromosomal localization of genes encoding the transcription factors, c-rel, NF-\u03baBp50, NF-\u03baBp65, and lyt-10 by fluorescence in situ hybridization. Oncogene 1993; 8: 191\u2013193.","journal-title":"Oncogene"},{"key":"BF2403171_CR17","first-page":"923","volume":"9","author":"CC Chang","year":"1994","unstructured":"Chang CC, Zhang J, Lombardi L, Neri A, Dalla-Favera R . Mechanism of expression and role in transcriptional control of the proto-oncogene NF\u03baB-2\/LYT-10. Oncogene 1994; 9: 923\u2013933.","journal-title":"Oncogene"},{"key":"BF2403171_CR18","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1182\/blood.V84.11.3850.bloodjournal84113850","volume":"84","author":"A Migliazza","year":"1994","unstructured":"Migliazza A, Lombardi L, Rocchi M, Trecca D, Chang CC, Antonacci R et al. chromosomal aberrations generate 3\u2032 truncations of the NF\u03baB2\/lyt-10 gene in lymphoid malignancies. Blood 1994; 84: 3850\u20133860.","journal-title":"Blood"},{"key":"BF2403171_CR19","first-page":"2335","volume":"9","author":"S Thakur","year":"1994","unstructured":"Thakur S, Lin HC, Tseng WT, Kumar S, Bravo R, Foss F et al. Rearrangement and altered expression of the NF\u03baB-2 gene in human cutaneous T-lymphoma cells. Oncogene 1994; 9: 2335\u20132344.","journal-title":"Oncogene"},{"key":"BF2403171_CR20","first-page":"1003","volume":"10","author":"P Dobrzanski","year":"1995","unstructured":"Dobrzanski P, Ryseck RP, Bravo R . Specific inhibition of RelB\/p52 transcriptional activity by the C-terminal domain of p100. Oncogene 1995; 10: 1003\u20131007.","journal-title":"Oncogene"},{"key":"BF2403171_CR21","doi-asserted-by":"crossref","first-page":"6201","DOI":"10.1038\/sj.onc.1203022","volume":"18","author":"M Heusch","year":"1999","unstructured":"Heusch M, Lin L, Geleziunas R, Greene WC . The generation of nf\u03bab2 p52: mechanism and efficiency. Oncogene 1999; 18: 6201\u20136208.","journal-title":"Oncogene"},{"key":"BF2403171_CR22","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/ncb872","volume":"4","author":"Y Wang","year":"2002","unstructured":"Wang Y, Cui H, Schroering A, Ding JL, Lane WS, McGill G et al. NF-\u03baB2 p100 is a pro-apoptotic protein with anti-oncogenic function. Nat Cell Biol 2002; 4: 888\u2013893.","journal-title":"Nat Cell Biol"},{"key":"BF2403171_CR23","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1535-6108(02)00213-1","volume":"2","author":"H Hacker","year":"2002","unstructured":"Hacker H, Karin M . Is NF-\u03baB2\/p100 a direct activator of programmed cell death? Cancer Cell 2002; 2: 431\u2013433.","journal-title":"Cancer Cell"},{"key":"BF2403171_CR24","first-page":"527","volume":"2","author":"E Brownell","year":"1988","unstructured":"Brownell E, Fell HP, Tucker PW, Geurts van Kessel AH, Hagemeijer A, Rice NR . Regional localization of the human c-rel locus using translocation chromosome analysis. Oncogene 1988; 2: 527\u2013529.","journal-title":"Oncogene"},{"key":"BF2403171_CR25","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1182\/blood.V91.11.4321","volume":"91","author":"TF Barth","year":"1998","unstructured":"Barth TF, Dohner H, Werner CA, Stilgenbauer S, Schlotter M, Pawlita M et al. Characteristic pattern of chromosomal gains and losses in primary large B-cell lymphomas of the gastrointestinal tract. Blood 1998; 91: 4321\u20134330.","journal-title":"Blood"},{"key":"BF2403171_CR26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1182\/blood.V87.1.25.25","volume":"87","author":"J Houldsworth","year":"1996","unstructured":"Houldsworth J, Mathew S, Rao PH, Dyomina K, Louie DC, Parsa N et al. REL proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma. Blood 1996; 87: 25\u201329.","journal-title":"Blood"},{"key":"BF2403171_CR27","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1182\/blood-2002-08-2577","volume":"101","author":"TF Barth","year":"2003","unstructured":"Barth TF, Martin-Subero JI, Joos S, Menz CK, Hasel C, Mechtersheimer G et al. Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma. Blood 2003; 101: 3681.","journal-title":"Blood"},{"key":"BF2403171_CR28","first-page":"257","volume":"5","author":"AJ Capobianco","year":"1990","unstructured":"Capobianco AJ, Simmons DL, Gilmore TD . Cloning and expression of a chicken c-rel cDNA: unlike p59v-rel, p68c-rel is a cytoplasmic protein in chicken embryo fibroblasts. Oncogene 1990; 5: 257\u2013265.","journal-title":"Oncogene"},{"key":"BF2403171_CR29","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/0-306-48158-8_10","volume":"115","author":"TD Gilmore","year":"2003","unstructured":"Gilmore TD . The Re1\/NF-\u03baB\/I kappa B signal transduction pathway and cancer. Cancer Treat Res 2003; 115: 241\u2013265.","journal-title":"Cancer Treat Res"},{"key":"BF2403171_CR30","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/0092-8674(90)90347-H","volume":"23","author":"H Ohno","year":"1990","unstructured":"Ohno H, Takimoto G, McKeithan TW . The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control. Cell 1990; 23: 991\u2013997.","journal-title":"Cell"},{"key":"BF2403171_CR31","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1080\/10428190290016935","volume":"43","author":"WY Au","year":"2002","unstructured":"Au WY, Horsman DE, Ohno H, Klasa RJ, Gascoyne RD . Bcl-3\/IgH translocation (14;19)(q32;q13) in non-Hodgkin's lymphomas. Leuk Lymphoma 2002; 43: 813\u2013816.","journal-title":"Leuk Lymphoma"},{"key":"BF2403171_CR32","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1182\/blood-2002-08-2464","volume":"101","author":"M Nishikori","year":"2003","unstructured":"Nishikori M, Maesako Y, Ueda C, Kurata M, Uchiyama T, Ohno H . High-level expression of BCL3 differentiates t(2;5)(p23;q35)-positive anaplastic large cell lymphoma from Hodgkin disease. Blood 2003; 101: 2789\u20132796.","journal-title":"Blood"},{"key":"BF2403171_CR33","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1093\/emboj\/16.12.3609","volume":"16","author":"N Watanabe","year":"1997","unstructured":"Watanabe N, Iwamura I, Shinoda T, Fujita T . Regulation of NFKB1 protein by the candidate oncoprotein BCL-3: generation of NF-\u03baB homodimers from the cytoplasmic pool of p50-p150 and nuclear translocation. EMBO J 1997; 16: 3609\u20133620.","journal-title":"EMBO J"},{"key":"BF2403171_CR34","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1093\/emboj\/18.17.4766","volume":"18","author":"V Heissmeyer","year":"1999","unstructured":"Heissmeyer V, Krappmann D, Wulczyn FG, Scheidereit C . NF-\u03baB p105 is a target of IkappaB kinases and controls signal induction of Bcl-3-p50 complexes. EMBO J 1999; 18: 4766\u20134778.","journal-title":"EMBO J"},{"key":"BF2403171_CR35","doi-asserted-by":"crossref","first-page":"6180","DOI":"10.1093\/emboj\/20.22.6180","volume":"20","author":"F Michel","year":"2001","unstructured":"Michel F, Soler-Lopez M, Petosa C, Cramer P, Siebenlist U, Muller CW . Crystal structure of the ankyrin repeat domain of Bcl-3: a unique member of the I\u03baB protein family. EMBO J 2001; 20: 6180\u20136190.","journal-title":"EMBO J"},{"key":"BF2403171_CR36","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1038\/sj.onc.1202717","volume":"18","author":"R Dechend","year":"1999","unstructured":"Dechend R, Hirano F, Lehmann K, Heissmeyer V, Ansieau S, Wulczyn FG et al. The Bcl-3 oncoprotein acts as a bridging factor between NF-\u03baB\/Rel and nuclear co-regulators. Oncogene 1999; 18: 3316\u20133323.","journal-title":"Oncogene"},{"key":"BF2403171_CR37","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0092-8674(00)80957-5","volume":"96","author":"TG Willis","year":"1999","unstructured":"Willis TG, Jadayel DM, Du MQ, Peng H, Perry AR, Abdul-Rauf M et al. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 1999; 96: 35\u201345.","journal-title":"Cell"},{"key":"BF2403171_CR38","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/8767","volume":"22","author":"Q Zhang","year":"1999","unstructured":"Zhang Q, Siebert R, Yan M, Hinzmann B, Cui X, Xue L et al. Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32). Nat Genet 1999; 22: 63\u201368.","journal-title":"Nat Genet"},{"key":"BF2403171_CR39","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1083\/jcb.148.6.1131","volume":"148","author":"C Guiet","year":"2000","unstructured":"Guiet C, Vito P . Caspase recruitment domain (CARD)-dependent cytoplasmic filaments mediate bcl10-induced NF-\u03baB activation. J Cell Biol 2000; 148: 1131\u20131140.","journal-title":"J Cell Biol"},{"key":"BF2403171_CR40","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1016\/S0960-9822(01)00668-6","volume":"12","author":"M Thome","year":"2002","unstructured":"Thome M, Tschopp J . Bcl10. Curr Biol 2002; 12: R45.","journal-title":"Curr Biol"},{"key":"BF2403171_CR41","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1038\/sj.onc.1204576","volume":"20","author":"D Yui","year":"2001","unstructured":"Yui D, Yoneda T, Oono K, Katayama T, Imaizumi K, Tohyama M . Interchangeable binding of Bcl10 to TRAF2 and cIAPs regulates apoptosis signaling. Oncogene 2001; 20: 4317\u20134323.","journal-title":"Oncogene"},{"key":"BF2403171_CR42","first-page":"283","volume":"19","author":"K Ohshima","year":"2001","unstructured":"Ohshima K, Muta H, Kawasaki C, Muta K, Deyev V, Kanda M et al. Bcl10 expression, rearrangement and mutation in MALT lymphoma: correlation with expression of nuclear factor-\u03baB. Int J Oncol 2001; 19: 283\u2013289.","journal-title":"Int J Oncol"},{"key":"BF2403171_CR43","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1182\/blood.V93.11.3601","volume":"93","author":"J Dierlamm","year":"1999","unstructured":"Dierlamm J, Baens M, Wlodarska I, Stefanova-Ouzounova M, Hernandez JM, Hossfeld DK et al. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood 1999; 93: 3601\u20133609.","journal-title":"Blood"},{"key":"BF2403171_CR44","first-page":"961","volume":"6","author":"AG Uren","year":"2000","unstructured":"Uren AG, O'Rourke K, Aravind LA, Pisabarro MT, Seshagiri S, Koonin EV et al. Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma. Mol Cell 2000; 6: 961\u2013967.","journal-title":"Mol Cell"},{"key":"BF2403171_CR45","doi-asserted-by":"crossref","first-page":"19012","DOI":"10.1074\/jbc.M009984200","volume":"276","author":"PC Lucas","year":"2001","unstructured":"Lucas PC, Yonezumi M, Inohara N, McAllister-Lucas LM, Abazeed ME, Chen FF et al. Bcl10 and MALT1, independent targets of chromosomal translocation in MALT lymphoma, cooperate in a novel NF-\u03baB signaling pathway. J Biol Chem 2001; 276: 19012\u201319019.","journal-title":"J Biol Chem"},{"key":"BF2403171_CR46","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1182\/blood-2002-10-3167","volume":"101","author":"H Ye","year":"2003","unstructured":"Ye H, Liu H, Raderer M, Chott A, Ruskone-Fourmestrsux A, Wotherspoon A et al. High incidence of t(11;18)(q21;21) in Helicobacter pylori-negative gastric MALT lymphoma. Blood 2003; 101: 2547\u20132550.","journal-title":"Blood"},{"key":"BF2403171_CR47","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1172\/JCI119849","volume":"100","author":"RC Bargou","year":"1997","unstructured":"Bargou RC, Emmerich F, Krappmann D, Bommert K, Mapara MY, Arnold W et al. Constitutive nuclear factor-\u03baB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest 1997; 100: 2961\u20132969.","journal-title":"J Clin Invest"},{"key":"BF2403171_CR48","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1182\/blood.V97.9.2798","volume":"97","author":"M Hinz","year":"2001","unstructured":"Hinz M, Loser P, Mathas S, Krappmann D, Dorken B, Scheidereit C . Constitutive NF-\u03baB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin\/Reed\u2013Sternberg cells. Blood 2001; 97: 2798\u20132807.","journal-title":"Blood"},{"key":"BF2403171_CR49","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/modpathol.3880306","volume":"14","author":"KF Izban","year":"2001","unstructured":"Izban KF, Ergin M, Huang Q, Qin JZ, Martinez RL, Schnitzer B et al. Characterization of NF-\u03baB expression in Hodgkin's disease: inhibition of constitutively expressed NF-\u03baB results in spontaneous caspase-independent apoptosis in Hodgkin and Reed\u2013Sternberg cells. Mod Pathol 2001; 14: 297\u2013310.","journal-title":"Mod Pathol"},{"key":"BF2403171_CR50","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1182\/blood.V94.9.3129","volume":"94","author":"F Emmerich","year":"1999","unstructured":"Emmerich F, Meiser M, Hummel M, Demel G, Foss HD, Jundt F et al. Overexpression of I\u03baB alpha without inhibition of NF-\u03baB activity and mutations in the I kappa B alpha gene in Reed\u2013Sternberg cells. Blood 1999; 94: 3129\u20133134.","journal-title":"Blood"},{"key":"BF2403171_CR51","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/S0002-9440(10)61112-1","volume":"160","author":"R Horie","year":"2002","unstructured":"Horie R, Watanabe T, Ito K, Morisita Y, Watanabe M, Ishida T et al. Cytoplasmic aggregation of TRAF2 and TRAF5 proteins in the Hodgkin\u2013Reed\u2013Sternberg cells. Am J Pathol 2002; 160: 1647\u20131654.","journal-title":"Am J Pathol"},{"key":"BF2403171_CR52","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1038\/sj.onc.1205337","volume":"21","author":"R Horie","year":"2002","unstructured":"Horie R, Watanabe T, Morishita Y, Ito K, Ishida T, Kanegae Y et al. Ligand-independent signaling by overexpressed CD30 drives NF-\u03baB activation in Hodgkin\u2013Reed\u2013Sternberg cells. Oncogene 2002; 21: 2493\u20132503.","journal-title":"Oncogene"},{"key":"BF2403171_CR53","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1359-6101(00)00028-9","volume":"12","author":"KT Jeang","year":"2001","unstructured":"Jeang KT . Functional activities of the human T-cell leukemia virus type I Tax oncoprotein: cellular signaling through NF-\u03baB. Cytokine Growth Factor Rev 2001; 12: 207\u2013217.","journal-title":"Cytokine Growth Factor Rev"},{"key":"BF2403171_CR54","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1182\/blood.V99.9.3367","volume":"99","author":"L Gu","year":"2002","unstructured":"Gu L, Findley HW, Zhou M . MDM2 induces NF-\u03baB\/p65 expression transcriptionally through Sp1-binding sites: a novel, p53-independent role of MDM2 in doxorubicin resistance in acute lymphoblastic leukemia. Blood 2002; 99: 3367\u20133375.","journal-title":"Blood"},{"key":"BF2403171_CR55","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1038\/sj.onc.1201411","volume":"15","author":"M Hamdane","year":"1997","unstructured":"Hamdane M, David-Cordonnier MH, D'Halluin JC . Activation of p65 NF-\u03baB protein by p210BCR-ABL in a myeloid cell line (P210BCR-ABL activates p65 NF-kappaB). Oncogene 1997; 15: 2267\u20132275.","journal-title":"Oncogene"},{"key":"BF2403171_CR56","doi-asserted-by":"crossref","first-page":"12294","DOI":"10.1074\/jbc.M211849200","volume":"278","author":"WS Wu","year":"2003","unstructured":"Wu WS, Xu ZX, Hittelman WN, Salomoni P, Pandolfi PP, Chang KS . Promyelocytic leukemia protein sensitizes tumor necrosis factor alpha-induced apoptosis by inhibiting the NF-\u03baB survival pathway. J Biol Chem 2003; 278: 12294\u201312304.","journal-title":"J Biol Chem"},{"key":"BF2403171_CR57","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/sj.gt.3301216","volume":"7","author":"MF Romano","year":"2000","unstructured":"Romano MF, Lamberti A, Bisogni R, Tassone P, Pagnini D, Storti G et al. of cytosine arabinoside-induced apoptosis in human myeloblastic leukemia cells by NF-\u03baB\/Rel-specific decoy oligodeoxynucleotides. Gene Ther 2000; 7: 1234\u20131237.","journal-title":"Gene Ther"},{"key":"BF2403171_CR58","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1182\/blood.V98.8.2301","volume":"98","author":"ML Guzman","year":"2001","unstructured":"Guzman ML, Neering SJ, Upchurch D, Grimes B, Howard DS, Rizzieri DA et al. Nuclear factor-\u03baB is constitutively activated in primitive human acute myelogenous leukemia cells. Blood 2001; 98: 2301\u20132307.","journal-title":"Blood"},{"key":"BF2403171_CR59","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/sj.leu.2402131","volume":"15","author":"C Wuchter","year":"2001","unstructured":"Wuchter C, Krappmann D, Cai Z, Ruppert V, Scheidereit C, Dorken B et al. In vitro susceptibility to TRAIL-induced apoptosis of acute leukemia cells in the context of TRAIL receptor gene expression and constitutive NF-\u03baB activity. Leukemia 2001; 15: 921\u2013928.","journal-title":"Leukemia"},{"key":"BF2403171_CR60","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1038\/sj.leu.2402641","volume":"16","author":"B Baumgartner","year":"2002","unstructured":"Baumgartner B, Weber M, Quirling M, Fischer C, Page S, Adam M et al. Increased IkappaB kinase activity is associated with activated NF-\u03baB in acute myeloid blasts. Leukemia 2002; 16: 2062\u20132071.","journal-title":"Leukemia"},{"key":"BF2403171_CR61","doi-asserted-by":"crossref","first-page":"16220","DOI":"10.1073\/pnas.252462599","volume":"99","author":"ML Guzman","year":"2002","unstructured":"Guzman ML, Swiderski CF, Howard DS, Grimes BA, Rossi RM, Szilvassy SJ et al. Preferential induction of apoptosis for primary human leukemic stem cells. Proc Natl Acad Sci USA 2002; 99: 16220\u201316225.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2403171_CR62","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/sj.leu.2402953","volume":"17","author":"MF Romano","year":"2003","unstructured":"Romano MF, Petrella A, Bisogni R, Turco MC, Venuta S . Effect of NF-\u03baB\/Rel inhibition on spontaneous vs chemotherapy-induced apoptosis in AML and normal cord blood CD34+cells. Leukemia 2003; 17: 1190\u20131192.","journal-title":"Leukemia"},{"key":"BF2403171_CR63","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1182\/blood.V92.3.990","volume":"92","author":"MF Romano","year":"1998","unstructured":"Romano MF, Lamberti A, Tassone P, Alfinito F, Costantini S, Chiurazzi F et al. Triggering of CD40 antigen inhibits fludarabine-induced apoptosis in B chronic lymphocytic leukemia cells. Blood 1998; 92: 990\u2013995.","journal-title":"Blood"},{"key":"BF2403171_CR64","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1182\/blood.V94.12.4060","volume":"94","author":"MF Romano","year":"1999","unstructured":"Romano MF, Lamberti A, Bisogni R, Garbi C, Pagnano AM, Auletta P et al. Amifostine inhibits hematopoietic progenitor cell apoptosis by activating NF-\u03baB\/Rel transcription factors. Blood 1999; 94: 4060\u20134066.","journal-title":"Blood"},{"key":"BF2403171_CR65","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1046\/j.1432-1033.2003.03555.x","volume":"270","author":"J Kurreck","year":"2003","unstructured":"Kurreck J . Antisense technologies. Improvement through novel chemical modifications. Eur J Biochem 2003; 270: 1628\u20131644.","journal-title":"Eur J Biochem"},{"key":"BF2403171_CR66","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1038\/sj.onc.1206262","volume":"22","author":"A Zhou","year":"2003","unstructured":"Zhou A, Scoggin S, Gaynor RB, Williams NS . Identification of NF-\u03baB-regulated genes induced by TNF\u03ba utilizing expression profiling and RNA interference. Oncogene 2003; 22: 2054\u20132064.","journal-title":"Oncogene"},{"key":"BF2403171_CR67","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/S1471-4914(02)02315-8","volume":"8","author":"J Adams","year":"2002","unstructured":"Adams J . Proteasome inhibition: a novel approach to cancer therapy. Trends Mol Med 2002; 8: S49\u201354.","journal-title":"Trends Mol Med"},{"key":"BF2403171_CR68","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1146\/annurev.biochem.67.1.265","volume":"67","author":"JW Mattaj","year":"1998","unstructured":"Mattaj JW, Englmeier L . Nuclecytoplasmic transport: the soluble phase. Annu Rev Biochem 1998; 67: 265\u2013306.","journal-title":"Annu Rev Biochem"},{"key":"BF2403171_CR69","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0163-7258(02)00186-9","volume":"93","author":"C Gould","year":"2002","unstructured":"Gould C, Wong CF . Designing specific protein kinase inhibitors: insights from computer simulations and comparative sequence\/structure analysis. Pharmacol Ther 2002; 93: 169\u2013178.","journal-title":"Pharmacol Ther"},{"key":"BF2403171_CR70","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1182\/blood.V93.10.3302.410a38_3302_3308","volume":"93","author":"DW Pyatt","year":"1999","unstructured":"Pyatt DW, Stillman WS, Yang Y, Gross S, Zheng JH, Irons RD . An essential role for NF-\u03baB in human CD34(+) bone marrow cell survival. Blood 1999; 93: 3302\u20133308.","journal-title":"Blood"},{"key":"BF2403171_CR71","doi-asserted-by":"crossref","first-page":"8081","DOI":"10.1073\/pnas.95.14.8081","volume":"95","author":"F Besancon","year":"1998","unstructured":"Besancon F, Atfi A, Gespach C, Cayre YE, Bourgeade MF . Evidence for a role of NF-\u03baB in the survival of hematopoietic cells mediated by interleukin 3 and oncogenic TEL\/platelet-derived growth factor receptor beta fusion protein. Proc Natl Acad Sci USA 1998; 95: 8081\u20138087.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2403171_CR72","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1126\/science.278.5338.687","volume":"278","author":"L del Peso","year":"1997","unstructured":"del Peso L, Gonzalez-Garcia M, Page C, Herrera R, Nunez G . Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 1997; 278: 687\u2013689.","journal-title":"Science"},{"key":"BF2403171_CR73","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1038\/sj.onc.1205318","volume":"21","author":"J Zhu","year":"2002","unstructured":"Zhu J, Emerson SG . Hematopoietic cytokines, transcription factors and lineage commitment. Oncogene 2002; 21: 3295\u20133313.","journal-title":"Oncogene"},{"key":"BF2403171_CR74","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1128\/MCB.19.5.3485","volume":"19","author":"GA Webster","year":"1999","unstructured":"Webster GA, Perkins ND . Transcriptional cross talk between NF-\u03baB and p53. Mol Cell Biol 1999; 19: 3485\u20133495.","journal-title":"Mol Cell Biol"},{"key":"BF2403171_CR75","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1084\/jem.20020062","volume":"196","author":"M Hinz","year":"2002","unstructured":"Hinz M, Lemke P, Anagnostopoulos I, Hacker C, Krappmann D, Mathas S et al. Nuclear factor \u03baB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity. J Exp Med 2002; 196: 605\u2013617.","journal-title":"J Exp Med"},{"key":"BF2403171_CR76","first-page":"290","volume":"63","author":"DK Biswas","year":"2003","unstructured":"Biswas DK, Martin KJ, McAlister C, Cruz AP, Graner E, Dai SC et al. Apoptosis caused by chemotherapeutic inhibition of nuclear factor-\u03baB activation. Cancer Res 2003; 63: 290\u2013295.","journal-title":"Cancer Res"},{"key":"BF2403171_CR77","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1128\/MCB.23.5.1520-1533.2003","volume":"23","author":"B Rayet","year":"2003","unstructured":"Rayet B, Fan Y, Gelinas C . Mutations in the v-Rel transactivation domain indicate altered phosphorylation and identify a subset of NF-\u03baB-regulated cell death inhibitors important for v-Rel transforming activity. Mol Cell Biol 2003; 23: 1520\u20131533.","journal-title":"Mol Cell Biol"},{"key":"BF2403171_CR78","first-page":"PE1","volume":"44","author":"BW Richter","year":"2000","unstructured":"Richter BW, Duckett CS . The IAP proteins: caspase inhibitors and beyond. Sci STKE 2000; 44: PE1.","journal-title":"Sci STKE"},{"key":"BF2403171_CR79","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrc968","volume":"3","author":"DC Altieri","year":"2003","unstructured":"Altieri DC . Validating survivin as a cancer therapeutic target. Nat Rev Cancer 2003; 3: 46\u201354.","journal-title":"Nat Rev Cancer"},{"key":"BF2403171_CR80","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1182\/blood.V98.7.2091","volume":"98","author":"S Fukuda","year":"2001","unstructured":"Fukuda S, Pelus LM . Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34(+) cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis. Blood 2001; 98: 2091\u20132100.","journal-title":"Blood"},{"key":"BF2403171_CR81","doi-asserted-by":"crossref","first-page":"322","DOI":"10.4161\/cc.1.5.149","volume":"1","author":"S Fukuda","year":"2002","unstructured":"Fukuda S, Pelus LM . Elevation of survivin levels by hematopoietic growth factors occurs in quiescent CD34+ hematopoietic stem and progenitor cells before cell cycle entry. Cell Cycle 2002; 1: 322\u2013326.","journal-title":"Cell Cycle"},{"key":"BF2403171_CR82","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1182\/blood.V100.7.2463","volume":"100","author":"S Fukuda","year":"2002","unstructured":"Fukuda S, Foster RG, Porter SB, Pelus LM . The antiapoptosis protein survivin is associated with cell cycle entry of normal cord blood CD34(+) cells and modulates cell cycle and proliferation of mouse hematopoietic progenitor cells. Blood 2002; 100: 2463\u20132471.","journal-title":"Blood"},{"key":"BF2403171_CR83","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0168-9525(00)02106-5","volume":"16","author":"M Holcik","year":"2000","unstructured":"Holcik M, Sonenberg N, Korneluk RG . Internal ribosome initiation of translation and the control of cell death. Trends Genet 2000; 16: 469\u2013473.","journal-title":"Trends Genet"},{"key":"BF2403171_CR84","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1128\/MCB.21.16.5299-5305.2001","volume":"21","author":"O Micheau","year":"2001","unstructured":"Micheau O, Lens S, Gaide O, Alevizopoulos K, Tschopp J . NF-\u03baB signals induce the expression of c-FLIP. Mol Cell Biol 2001; 21: 5299\u20135305.","journal-title":"Mol Cell Biol"},{"key":"BF2403171_CR85","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/sj.onc.1206056","volume":"22","author":"M Bentires-Alj","year":"2003","unstructured":"Bentires-Alj M, Barbu V, Fillet M, Chariot A, Relic B, Jacobs N et al. NF-\u03baB transcription factor induces drug resistance through MDR1 expression in cancer cells. Oncogene 2003; 22: 90\u201397.","journal-title":"Oncogene"},{"key":"BF2403171_CR86","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1128\/MCB.19.9.5923","volume":"19","author":"CY Wang","year":"1999","unstructured":"Wang CY, Guttridge DC, Mayo MW, Baldwin Jr AS . NF-\u03baB induces expression of the Bcl-2 homologue A1\/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis. Mol Cell Biol 1999; 19: 5923\u20135929.","journal-title":"Mol Cell Biol"},{"key":"BF2403171_CR87","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1101\/gad.13.4.382","volume":"13","author":"WX Zong","year":"1999","unstructured":"Zong WX, Edelstein LC, Chen C, Bash J, Gelinas C . The prosurvival Bcl-2 homolog Bfl-1\/A1 is a direct transcriptional target of NF-\u03baB that blocks TNFalpha-induced apoptosis. Genes Dev 1999; 13: 382\u2013387.","journal-title":"Genes Dev"},{"key":"BF2403171_CR88","doi-asserted-by":"crossref","first-page":"6970","DOI":"10.1128\/MCB.17.12.6970","volume":"17","author":"PL Jones","year":"1997","unstructured":"Jones PL, Ping D, Boss JM . Tumor necrosis factor alpha and interleukin-1beta regulate the murine manganese superoxide dismutase gene through a complex intronic enhancer involving C\/EBP-beta and NF-\u03baB. Mol Cell Biol 1997; 17: 6970\u20136981.","journal-title":"Mol Cell Biol"},{"key":"BF2403171_CR89","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1083\/jcb.145.7.1471","volume":"145","author":"K Heyninck","year":"1999","unstructured":"Heyninck K, De Valck D, Vanden Berghe W, Van Criekinge W, Contreras R, Fiers W et al. The zinc finger protein A20 inhibits TNF-induced NF-\u03baB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-\u03baB-inhibiting protein ABIN. J Cell Biol 1999; 145: 1471\u20131482.","journal-title":"J Cell Biol"},{"key":"BF2403171_CR90","first-page":"26034","volume":"22","author":"KL He","year":"2002","unstructured":"He KL, Ting AT . A20 inhibits tumor necrosis factor (TNF) alpha-induced apoptosis by disrupting recruitment of TRADD and RIP to the TNF receptor 1 complex in Jurkat T cells. Mol Cell Biol 2002; 22: 26034\u201326045.","journal-title":"Mol Cell Biol"},{"key":"BF2403171_CR91","first-page":"RE5","volume":"172","author":"H Tran","year":"2003","unstructured":"Tran H, Brunet A, Griffith EC, Greenberg ME . The many forks in FOXO's road. Sci STKE 2003; 172: RE5.","journal-title":"Sci STKE"},{"key":"BF2403171_CR92","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1038\/sj.onc.1204292","volume":"20","author":"S Nozaki","year":"2001","unstructured":"Nozaki S, Sledge Jr GW, Nakshatri H . Repression of GADD153\/CHOP by NF-\u03baB: a possible cellular defense against endoplasmic reticulum stress-induced cell death. Oncogene 2001; 20: 2178\u20132185.","journal-title":"Oncogene"},{"key":"BF2403171_CR93","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0166-2236(00)01819-1","volume":"24","author":"V Mollace","year":"2001","unstructured":"Mollace V, Nottet HS, Clayette P, Turco MC, Muscoli C, Salvemini D et al. Oxidative stress and neuroAIDS: triggers, modulators and novel antioxidants. Trends Neurosci 2001; 24: 411\u2013416.","journal-title":"Trends Neurosci"},{"key":"BF2403171_CR94","first-page":"18","volume":"63","author":"M Akiyama","year":"2003","unstructured":"Akiyama M, Hideshima T, Hayashi T, Tai YT, Mitsiades CS, Mitsiades N et al. Nuclear factor-\u03baB p65 mediates tumor necrosis factor alpha-induced nuclear translocation of telomerase reverse transcriptase protein. Cancer Res 2003; 63: 18\u201321.","journal-title":"Cancer Res"},{"key":"BF2403171_CR95","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1046\/j.1365-2141.2001.03102.x","volume":"115","author":"H Ni","year":"2001","unstructured":"Ni H, Ergin M, Huang Q, Qin JZ, Amin HM, Martinez RL et al. Analysis of expression of nuclear factor kappa B (NF-\u03baB) in multiple myeloma: downregulation of NF-kappa B induces apoptosis. Br J Haematol 2001; 115: 279\u2013286.","journal-title":"Br J Haematol"},{"key":"BF2403171_CR96","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1182\/blood.V99.11.4079","volume":"99","author":"N Mitsiades","year":"2002","unstructured":"Mitsiades N, Mitsiades CS, Poulaki V, Chauhan D, Richardson PG, Hideshima T et al. Biologic sequelae of nuclear factor-\u03baB blockade in multiple myeloma: therapeutic applications. Blood 2002; 99: 4079\u20134086.","journal-title":"Blood"},{"key":"BF2403171_CR97","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0165-4608(02)00541-1","volume":"137","author":"KM Parker","year":"2002","unstructured":"Parker KM, Ma MH, Manyak S, Altamirano CV, Tang YM, Frantzen M et al. Identification of polymorphisms of the I\u03baB\u03ba gene associated with an increased risk of multiple myeloma. Cancer Genet Cytogenet 2002; 137: 43\u201348.","journal-title":"Cancer Genet Cytogenet"},{"key":"BF2403171_CR98","doi-asserted-by":"crossref","first-page":"5673","DOI":"10.1038\/sj.onc.1205664","volume":"21","author":"CS Mitsiades","year":"2002","unstructured":"Mitsiades CS, Mitsiades N, Poulaki V, Schlossman R, Akiyama M, Chauhan D et al. Activation of NF-\u03baB and upregulation of intracellular anti-apoptotic proteins via the IGF-1\/Akt signaling in human multiple myeloma cells: therapeutic implications. Oncogene 2002; 21: 5673\u20135683.","journal-title":"Oncogene"},{"key":"BF2403171_CR99","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1182\/blood.V93.9.3044","volume":"93","author":"R Feinman","year":"1999","unstructured":"Feinman R, Koury J, Thames M, Barlogie B, Epstein J, Siegel DS . Role of NF-\u03baB in the rescue of multiple myeloma cells from glucocorticoid-induced apoptosis by bcl-2. Blood 1999; 93: 3044\u20133052.","journal-title":"Blood"},{"key":"BF2403171_CR100","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1182\/blood.V99.12.4525","volume":"99","author":"N Mitsiades","year":"2002","unstructured":"Mitsiades N, Mitsiades CS, Poulaki V, Chauhan D, Richardson PG, Hideshima T et al. Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications. Blood 2002; 99: 4525\u20134530.","journal-title":"Blood"},{"key":"BF2403171_CR101","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1182\/blood.V98.3.795","volume":"98","author":"CS Mitsiades","year":"2001","unstructured":"Mitsiades CS, Treon SP, Mitsiades N, Shima Y, Richardson P, Schlossman R et al. TRAIL\/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications. Blood 2001; 98: 795\u2013804.","journal-title":"Blood"},{"key":"BF2403171_CR102","doi-asserted-by":"crossref","first-page":"16639","DOI":"10.1074\/jbc.M200360200","volume":"277","author":"T Hideshima","year":"2002","unstructured":"Hideshima T, Chauhan D, Richardson P, Mitsiades C, Mitsiades N, Hayashi T et al. NF-\u03baB as a therapeutic target in multiple myeloma. J Biol Chem 2002; 277: 16639\u201316647.","journal-title":"J Biol Chem"},{"key":"BF2403171_CR103","first-page":"165","volume":"22","author":"C Testorelli","year":"2003","unstructured":"Testorelli C . Telomerase and cancer. J Exp Clin Cancer Res 2003; 22: 165\u2013169.","journal-title":"J Exp Clin Cancer Res"},{"key":"BF2403171_CR104","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nrc906","volume":"2","author":"JE Darnell Jr","year":"2002","unstructured":"Darnell Jr JE . Transcription factors as targets for cancer therapy. Nat Rev Cancer 2002; 2: 740\u2013749.","journal-title":"Nat Rev Cancer"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2403171.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403171","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403171.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T01:25:48Z","timestamp":1648776348000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2403171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10,23]]},"references-count":104,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1,1]]}},"alternative-id":["BF2403171"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2403171","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,10,23]]},"assertion":[{"value":"16 July 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2003","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}